Product Images Toviaz

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Toviaz NDC 0069-0244 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - toviaz 01

Chemical Structure - toviaz 01

Figure 1 - toviaz 02

Figure 1 - toviaz 02

The text describes a figure (Figure 1) that shows the mean change from baseline in the number of micturitions per 24 hours in a study (Study 1). The study examined the effect of a drug called Toviaz (in two different doses) compared to a placebo. The data are presented in three different time points: 2, 8, and 12 weeks. The number of participants in each group (Placebo, Toviaz 4mg, and Toviaz 8mg) is provided.*

Figure 2 - toviaz 03

Figure 2 - toviaz 03

The text describes a figure with three lines representing the mean change from baseline for different treatments on urge incontinence episodes per 24 hours over a period of 12 weeks. The treatments are a placebo, Toviazdmg, and Toviaz8mg. There are 211 participants in the placebo group, 199 in the Toviazdmg group, and 223 in the Toviaz8mg group.*

Figure 3 - toviaz 04

Figure 3 - toviaz 04

The text describes a figure showing the change in the number of micturitions (urination) per day over a period of 12 weeks in a study that had three groups: a placebo group with 266 participants, a group taking Toviaz4mg with 267 participants, and a group taking Toviaz8mg with 267 participants. The figure shows the mean change from baseline.*

Figure 4 - toviaz 05

Figure 4 - toviaz 05

The text describes a graph showing the mean change in urge incontinence episodes per 24 hours over the course of a study. The study had four different groups, including a placebo group and three groups taking different doses of the medication Toviaz. The graph displays results from week 0, week 2, week 8, and week 12 of the study.*

Logo - toviaz 06

Logo - toviaz 06

Pfizer Labs, a division of Pfizer Inc. located in New York City (zip code 10017), distributes products related to healthcare.*

Logo - toviaz 07

Logo - toviaz 07

This is a label indicating that the product is distributed by Pfizer Labs, a division of Pfizer Inc., based in New York, NY 10017.*

PRINCIPAL DISPLAY PANEL - 4 mg Tablet Bottle Label - toviaz 08

PRINCIPAL DISPLAY PANEL - 4 mg Tablet Bottle Label - toviaz 08

This is a description of a medication called Toviaz, which is distributed by Pfizer Labs. The medication comes in the form of extended-release tablets and is prescribed for use in treating urinary disorders. The tablets should be stored between 15°C to 30°C and protected from moisture. The prescription is available in 4mg and is only available with a prescription. The text includes the medicine's National Drug Code (NDC) number and manufacturing information.*

PRINCIPAL DISPLAY PANEL - 8 mg Tablet Bottle Label - toviaz 09

PRINCIPAL DISPLAY PANEL - 8 mg Tablet Bottle Label - toviaz 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.